Brazil's health inspection agency approves the import of 6 million doses of China's new crown vaccine

China Vaccine

According to British Reuters news agency, the Brazilian Health Surveillance Agency (ANVISA) stated in a statement on the 23rd that it has authorized the Biomedical Center of the Butantan Institute of Sao Paulo to import 6 million doses of China Beijing Kexing Biological Products Co., Ltd. (Sinovac) New crown vaccine developed.

The Brazilian Health Surveillance Agency stated that the vaccine called "CoronaVac" is still in Phase III clinical trials in Brazil and has not been registered and widely used in Brazil.

Brazilian officials have previously stated that they plan to use the Chinese new crown vaccine as part of Brazil's national immunization plan. Sao Paulo Governor Doria has revealed that the Brazilian Federal Government has agreed to purchase 46 million doses of the "CoronaVac" vaccine. However, Brazilian President Bolsonaro suddenly announced on October 21 that he would not buy China's new crown vaccine, which caught many local governments by surprise. On October 23, Brazilian Federal Member Figari stated that the Brazilian Communist Party and other parties planned to appeal to the court against Bolsonaro’s ban on the purchase of 46 million doses of Chinese vaccines.

Brazil is currently the third country in the world with the most confirmed cases of new coronary pneumonia. According to the latest data released by the Brazilian Ministry of Health on the evening of October 23, local time, there were 21,022 new confirmed cases of new coronary pneumonia in the country in a single day, with a total of 5,353,656 confirmed cases; 571 new deaths and a total of 156,471 deaths. (Overseas Net Zhang Qi)

This article is a copyright work, unauthorized reproduction is strictly prohibited. For overseas vision and China's position, visit the official website of the Overseas Edition of People's Daily-www.haiwainet.cn or the "Haike" client to get authoritative information one step ahead.